When it comes to IBS-specific research, however, the evidence is still emerging and limited
Due to their cost, however, coverage of GLP-1s for obesity treatment in Medicaid, ACA Marketplace plans, and most large employer firms remains limited, and GLP-1 coverage in Medicare for treatment of obesity is prohibited under current law
If considering the Compounded Tablets tier: ask your assigned provider directly about the bioavailability and absorption pathway for compounded oral GLP-1 peptide medications, and what clinical evidence supports the specific oral formulation being prescribed
Katta S, Kaur I, Chakrabarti S
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage type 2 diabetes in the UK